Navinci Diagnostics
PrivateLast Round
Early Funding
Jun 25, 2025
Total Funding Raised
$14.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Navinci Diagnostics operates in Healthcare & Life Sciences and is based in Uppsala. Its latest recorded funding round was an Early Funding round in June 2025.
Navinci Diagnostics is a biotechnology company that develops and markets in situ proximity ligation assays to detect proteins, their interactions, and modifications in tissue and cell samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navinci Diagnostics Comparables
Compare Navinci Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pixelgen Technologies | 81% | |
| Bio-Techne Corporation | 76% | |
| Vizgen | 76% |
For institutional investors. Book with your work email.
Navinci Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 25, 2025 | ||||
| Series A | Jul 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Navinci Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Meltwind Advisory | Early Funding |
| Segulah Medical Acceleration | Early Funding, Series A |
| NXT2B | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 42% MoM, reaching 8.8K.
- Jan 22, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 18, 2026
Navinci Diagnostics AB partnered with BrainZell AB on Aug 18th '26.
For institutional investors. Book with your work email.
Navinci Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Navinci Diagnostics's valuation, stock price, and market status.
Is Navinci Diagnostics a public or private company?
Navinci Diagnostics is a private company.
What is the current stock price of Navinci Diagnostics?
Navinci Diagnostics is a private company, so its shares have no public market price. Caplight tracks Navinci Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Navinci Diagnostics worth (valuation)?
Valuation information for Navinci Diagnostics is not publicly available.
Can I buy Navinci Diagnostics stock?
Navinci Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Navinci Diagnostics's last funding round?
Navinci Diagnostics's most recent funding round was Early Funding on June 25, 2025.
Who are the main investors in Navinci Diagnostics?
Key investors in Navinci Diagnostics include Segulah Medical Acceleration.
Will Navinci Diagnostics IPO soon?
No public IPO plans have been announced for Navinci Diagnostics.
How can I track Navinci Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Navinci Diagnostics's shares on secondary markets.